Having trouble accessing articles? Reset your cache.

HuDS6-DM4: Phase I started

sanofi-aventis began an open-label, dose-escalation Phase I trial to

Read the full 99 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE